Exenatide once weekly versus placebo in Parkinson's disease: a randomised, double-blind, placebo-controlled trial
University College London · National Hospital for Neurology and Neurosurgery · +3 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
841
total citations
- FWCI
- 47.81
- Percentile
- 100%
- References
- 38
Citations per year
Authors
18Topics & keywords
Topics
Keywords
- Medicine
- Exenatide
- Placebo
- Internal medicine
- Parkinson's disease
- Randomized controlled trial
- Physical therapy
- Clinical trial
UN Sustainable Development Goals
- Good health and well-being
No related works found for this paper.